Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
US Army
McKinsey
Medtronic
Colorcon
Harvard Business School
Julphar
AstraZeneca
Farmers Insurance
Chubb

Generated: February 21, 2018

DrugPatentWatch Database Preview

Adenosine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for adenosine and what is the scope of adenosine patent protection?

Adenosine
is the generic ingredient in three branded drugs marketed by Astellas, Akorn, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Hospira Inc, and Mylan Asi, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for adenosine. Eighteen suppliers are listed for this compound. There are three tentative approvals for this compound.
Pharmacology for adenosine
Medical Subject Heading (MeSH) Categories for adenosine
Tentative approvals for ADENOSINE
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up3MG/MLINJECTABLE; INJECTION
➤ Sign Up➤ Sign Up3MG/MLINJECTABLE; INJECTION
➤ Sign Up➤ Sign Up3MG/MLINJECTABLE; INJECTION

US Patents and Regulatory Information for adenosine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ADENOSINE adenosine SOLUTION;IV (INFUSION) 205331-001 Nov 2, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Asi ADENOSINE adenosine SOLUTION;IV (INFUSION) 090212-002 Mar 28, 2014 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gland Pharma Ltd ADENOSINE adenosine INJECTABLE;INJECTION 077283-001 Jun 14, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn ADENOSINE adenosine SOLUTION;IV (INFUSION) 090450-001 Oct 2, 2014 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa ADENOSINE adenosine INJECTABLE;INJECTION 077133-001 Apr 27, 2005 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd ADENOSINE adenosine INJECTABLE;INJECTION 078640-001 Mar 21, 2014 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd ADENOSINE adenosine INJECTABLE;INJECTION 078686-001 May 13, 2009 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ADENOSINE adenosine SOLUTION;IV (INFUSION) 077425-002 Aug 29, 2013 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa ADENOSINE adenosine SOLUTION;IV (INFUSION) 077897-002 Nov 27, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn ADENOSINE adenosine INJECTABLE;INJECTION 078076-001 Oct 31, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for adenosine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astellas ADENOCARD adenosine INJECTABLE;INJECTION 019937-002 Oct 30, 1989 ➤ Sign Up ➤ Sign Up
Astellas ADENOSCAN adenosine SOLUTION;IV (INFUSION) 020059-002 May 18, 1995 ➤ Sign Up ➤ Sign Up
Astellas ADENOSCAN adenosine SOLUTION;IV (INFUSION) 020059-001 May 18, 1995 ➤ Sign Up ➤ Sign Up
Astellas ADENOSCAN adenosine SOLUTION;IV (INFUSION) 020059-001 May 18, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Dow
Colorcon
Daiichi Sankyo
Johnson and Johnson
McKesson
Argus Health
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot